View Item 

Show simple item record

Prostaglandin D2 receptor d ‐type prostanoid receptor 2 mediates eosinophil trafficking into the esophagus
dc.contributor.authorZhang, S.en_US
dc.contributor.authorWu, X.en_US
dc.contributor.authorYu, S.en_US
dc.date.accessioned2014-08-06T16:49:48Z
dc.date.availableWITHHELD_13_MONTHSen_US
dc.date.available2014-08-06T16:49:48Z
dc.date.issued2014-08en_US
dc.identifier.citationZhang, S.; Wu, X.; Yu, S. (2014). "Prostaglandin D2 receptor d ‐type prostanoid receptor 2 mediates eosinophil trafficking into the esophagus." Diseases of the Esophagus (6): 601-606.en_US
dc.identifier.issn1120-8694en_US
dc.identifier.issn1442-2050en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/108045
dc.publisherWiley Periodicals, Inc.en_US
dc.subject.otherEosinophilic Esophagitis ( EoE )en_US
dc.subject.otherProstaglandin D2en_US
dc.subject.otherMast Cellen_US
dc.titleProstaglandin D2 receptor d ‐type prostanoid receptor 2 mediates eosinophil trafficking into the esophagusen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelOtolaryngologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/108045/1/dote12118.pdf
dc.identifier.doi10.1111/dote.12118en_US
dc.identifier.sourceDiseases of the Esophagusen_US
dc.identifier.citedreferenceMonneret G, Gravel S, Diamond M, Rokach J, Powell W S. Prostaglandin D2 is a potent chemoattractant for human eosinophils that acts via a novel DP receptor. Blood 2001; 98: 1942 – 1948.en_US
dc.identifier.citedreferenceYu S, Stahl E, Li Q, Ouyang A. Antigen inhalation induces mast cells and eosinophils infiltration in the guinea pig esophageal epithelium involving histamine‐mediated pathway. Life Sci 2008; 82: 324 – 330.en_US
dc.identifier.citedreferenceHamid‐Bloomfield S, Whittle B J. Antagonism of PGD2 vasodepressor responses in the rat in vivo by the novel, selective antagonist, BW A868C. Br J Pharmacol 1989; 96: 307 – 312.en_US
dc.identifier.citedreferenceShiraishi Y, Asano K, Nakajima T et al. Prostaglandin D2‐induced eosinophilic airway inflammation is mediated by CRTH2 receptor. J Pharmacol Exp Ther 2005; 312: 954 – 960.en_US
dc.identifier.citedreferenceYu S, Kollarik M, Ouyang A, Myers A C, Undem B J. Mast cell‐mediated long‐lasting increases in excitability of vagal C fibers in guinea pig esophagus. Am J Physiol Gastrointest Liver Physiol 2007; 293: G850 – 856.en_US
dc.identifier.citedreferencePettipher R. The roles of the prostaglandin D(2) receptors DP(1) and CRTH2 in promoting allergic responses. Br J Pharmacol 2008; 153 ( Suppl 1 ): S191 – 199. Review.en_US
dc.identifier.citedreferenceSchuligoi R, Sturm E, Luschnig P et al. CRTH2 and d‐type prostanoid receptor antagonists as novel therapeutic agents for inflammatory diseases. Pharmacology 2010; 85: 372 – 382. Review.en_US
dc.identifier.citedreferenceMatsuoka T, Hirata M, Tanaka H et al. Prostaglandin D2 as a mediator of allergic asthma. Science 2000; 287: 2013 – 2017.en_US
dc.identifier.citedreferenceHirai H, Tanaka K, Yoshie O et al. Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven‐transmembrane receptor CRTH2. J Exp Med 2001; 193: 255 – 261.en_US
dc.identifier.citedreferenceWoodward D F, Jones R L, Narumiya S. International Union of Basic and Clinical Pharmacology. LXXXIII: classification of prostanoid receptors, updating 15 years of progress. Pharmacol Rev 2011; 63: 471 – 538. Review.en_US
dc.identifier.citedreferenceAlmishri W, Cossette C, Rokach J, Martin J G, Hamid Q, Powell W S. Effects of prostaglandin D2, 15‐deoxy‐Delta12,14‐prostaglandin J2, and selective DP1 and DP2 receptor agonists on pulmonary infiltration of eosinophils in Brown Norway rats. J Pharmacol Exp Ther 2005; 313: 64 – 69.en_US
dc.identifier.citedreferenceSatoh T, Moroi R, Aritake K et al. Prostaglandin D2 plays an essential role in chronic allergic inflammation of the skin via CRTH2 receptor. J Immunol 2006; 177: 2621 – 2629.en_US
dc.identifier.citedreferenceSpik I, Brénuchon C, Angéli V et al. Activation of the prostaglandin D2 receptor DP2/CRTH2 increases allergic inflammation in mouse. J Immunol 2005; 174: 3703 – 3708.en_US
dc.identifier.citedreferenceHe R, Oyoshi M K, Wang J Y, Hodge M R, Jin H, Geha R S. The prostaglandin D2 receptor CRTH2 is important for allergic skin inflammation after epicutaneous antigen challenge. J Allergy Clin Immunol 2010; 126: 784 – 790.en_US
dc.identifier.citedreferenceSchratl P, Royer J F, Kostenis E et al. The role of the prostaglandin D2 receptor, DP, in eosinophil trafficking. J Immunol 2007; 179: 4792 – 4799.en_US
dc.identifier.citedreferenceShichijo M, Sugimoto H, Nagao K et al. Chemoattractant receptor‐homologous molecule expressed on Th2 cells activation in vivo increases blood leukocyte counts and its blockade abrogates 13,14‐dihydro‐15‐keto‐prostaglandin D2‐induced eosinophilia in rats. J Pharmacol Exp Ther 2003; 307: 518 – 525.en_US
dc.identifier.citedreferenceSugimoto H, Shichijo M, Iino T et al. An orally bioavailable small molecule antagonist of CRTH2, ramatroban (BAY u3405), inhibits prostaglandin D2‐induced eosinophil migration in vitro. J Pharmacol Exp Ther 2003; 305: 347 – 352.en_US
dc.identifier.citedreferenceYamamoto Y, Otani S, Hirai H et al. Dual functions of prostaglandin D2 in murine contact hypersensitivity via DP and CRTH2. Am J Pathol 2011; 179: 302 – 314.en_US
dc.identifier.citedreferenceStraumann A, Aceves S S, Blanchard C et al. Pediatric and adult eosinophilic esophagitis: similarities and differences. Allergy 2012; 67: 477 – 490.en_US
dc.identifier.citedreferenceLiacouras C A, Furuta G T, Hirano I et al. Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol 2011; 128: 3 – 20.en_US
dc.identifier.citedreferenceMueller S, Aigner T, Neureiter D, Stolte M. Eosinophil infiltration and degranulation in oesophageal mucosa from adult patients with eosinophilic oesophagitis: a retrospective and comparative study on pathological biopsy. J Clin Pathol 2006; 59: 1175 – 1180.en_US
dc.identifier.citedreferenceKato M, Kephart G M, Talley N J et al. Eosinophil infiltration and degranulation in normal human tissue. Anat Rec 1998; 252: 418 – 425.en_US
dc.identifier.citedreferenceAllende D S, Yerian L M. Diagnosing gastroesophageal reflux disease: the pathologist's perspective. Adv Anat Pathol 2009; 16: 161 – 165. Review.en_US
dc.identifier.citedreferenceStraumann A, Conus S, Grzonka P et al. Anti‐interleukin‐5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo‐controlled, double‐blind trial. Gut 2010; 59: 21 – 30.en_US
dc.identifier.citedreferenceGonsalves N, Yang G Y, Doerfler B, Ritz S, Ditto A M, Hirano I. Elimination diet effectively treats eosinophilic esophagitis in adults; food reintroduction identifies causative factors. Gastroenterology 2012; 142: 1451 – 1459.en_US
dc.identifier.citedreferenceKirsch R, Bokhary R, Marcon M A, Cutz E. Activated mucosal mast cells differentiate eosinophilic (allergic) esophagitis from gastroesophageal reflux disease. J Pediatr Gastroenterol Nutr 2007; 44: 20 – 26.en_US
dc.identifier.citedreferenceKonikoff M R, Noel R J, Blanchard C et al. A randomized, double‐blind, placebo‐controlled trial of fluticasone propionate for pediatric eosinophilic esophagitis. Gastroenterology 2006; 131: 1381 – 1391.en_US
dc.identifier.citedreferenceStraumann A, Bauer M, Fischer B, Blaser K, Simon H U. Idiopathic eosinophilic esophagitis is associated with a T(H)2‐type allergic inflammatory response. J Allergy Clin Immunol 2001; 108: 954 – 961.en_US
dc.identifier.citedreferenceAbonia J P, Blanchard C, Butz B B et al. Involvement of mast cells in eosinophilic esophagitis. J Allergy Clin Immunol 2010; 126: 140 – 149.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
dote12118.pdf
Size:
458.4KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.